Situation: A nurse works at a Rural Health Unit (RHU) that provides prenatal care, a birthing facility, and a clinic for sick young infants. A preterm baby weighing 1.8 kg is born at the facility to a mother who tested positive for hepatitis B surface antigen (HBsAg) during pregnancy. The baby is stable. Which plan for the hepatitis B vaccine and hepatitis B immune globulin (HBIG) is CORRECT?

Two rules apply. The infant of an HBsAg-positive mother receives both the hepatitis B vaccine and HBIG within 12 hours of birth, whatever the birth weight, to prevent mother-to-child transmission. Because the baby weighs less than 2 kg, this birth dose is not counted, so she still needs 3 more hepatitis B-containing doses in the routine series.

Core rule for infants of HBsAg-positive mothers

When a mother is positive for hepatitis B surface antigen (HBsAg), the newborn is at high risk of perinatal hepatitis B virus (HBV) infection. The preventive strategy does not depend on the infant’s weight or clinical stability alone. Both hepatitis B vaccine and hepatitis B immune globulin (HBIG) must be given within 12 hours of birth. This immediate dual prophylaxis interrupts the transmission chain before the virus can establish infection in the neonatal liver.

For any infant born to an HBsAg-positive mother, the first hepatitis B vaccine dose and HBIG are administered within 12 hours of birth regardless of birth weight. This is the foundational principle that makes option 1 and option 3 the only candidates, and it eliminates option 2 (delaying vaccine until the baby reaches 2 kg) and option 4 (waiting for the infant’s own test result before giving HBIG).

Why the birth dose is not counted for a 1.8 kg preterm infant

The baby in this scenario weighs 1.8 kg, which is below the 2 kg threshold. For preterm or low-birth-weight infants under 2 kg born to HBsAg-positive mothers, the birth dose of hepatitis B vaccine is considered a supplementary dose rather than the first dose of the routine series. The reason is immunologic: very small preterm infants may mount a weaker or less durable antibody response to the birth dose, so relying on it as the first official dose could leave a gap in long-term protection.

Because the infant weighs less than 2 kg, the dose given at birth is not counted as part of the routine hepatitis B series, and the infant still requires three additional hepatitis B–containing doses afterward. This creates a 4-dose total schedule for this infant: the birth dose plus three routine doses.

Distinguishing the two 12-hour options

Option	Timing	Counting rule for a 1.8 kg infant	Correct?
1	Vaccine and HBIG within 12 hours	Counted as first dose	No — under 2 kg, the birth dose is not counted
3	Vaccine and HBIG within 12 hours	Not counted; 3 more doses needed	Yes

Watch out! The difference between option 1 and option 3 is not about whether to give the vaccine or HBIG. Both are given within 12 hours. The distinction is purely about dose counting. A 1.8 kg preterm infant does not get credit for the birth dose, so the total number of hepatitis B vaccine doses becomes four, not three.

Clinical reasoning from the evidence

The retrospective study by Qin and colleagues evaluated implementation of a 4-dose hepatitis B vaccine schedule for preterm and low-birth-weight infants born to HBsAg-positive mothers, reflecting the same principle applied in this question: the birth dose is given but not counted, and additional doses complete the series ^[1]. This aligns with the recommendation that preterm infants under 2 kg receive a total of four doses when the mother is HBsAg-positive.

The Singapore study by Tan and colleagues explicitly describes the Advisory Committee on Immunization Practices (ACIP) framework: a 4-dose schedule for preterm low-birth-weight infants under 2 kg and a 3-dose schedule for preterm infants weighing 2 kg or more, both born to HBsAg-positive mothers ^[3]. This confirms that the 2 kg cutoff is the decisive factor for whether the birth dose is counted.

Shen and colleagues demonstrated that the hepatitis B vaccination series in preterm infants is highly immunogenic, with an overall seroprotection rate of 99.43% after completing the series ^[2]. This supports the safety and effectiveness of giving the full series, including the uncounted birth dose, rather than withholding or delaying vaccination.

Key point! The birth dose for an infant under 2 kg born to an HBsAg-positive mother is not wasted — it provides early protection while the infant is most vulnerable. It is simply not counted toward the routine series, which is why three more doses are still required.

Why the other options fail

Option 2 delays the vaccine until the infant reaches 2 kg, which leaves a dangerous window without active immunization. The infant still receives HBIG, but HBIG alone provides only passive, temporary antibody coverage. Delaying the vaccine increases the risk of HBV infection during the neonatal period, especially when the mother is HBsAg-positive and the infant may have been exposed during delivery.

Option 4 waits for the infant’s own HBsAg test result before giving HBIG. This is incorrect because the infant’s test result may not yet be positive even when infection is incubating, and waiting forfeits the critical 12-hour window for post-exposure prophylaxis. The decision to give HBIG is based on the mother’s HBsAg status, not the infant’s test result at birth.

Putting it together for this 1.8 kg infant

The correct plan is to administer both the hepatitis B vaccine and HBIG within 12 hours of birth. Because the infant weighs 1.8 kg, this birth dose is not counted as the first dose of the routine series. The infant will need three additional hepatitis B–containing doses, making a total of four doses. This approach maximizes early protection against perinatal transmission while acknowledging the reduced immunologic reliability of the birth dose in very small preterm infants.